Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9

Autor: Lidegaard, O, Nielsen, L., Skovlund, CW, Skjeldestad, Finn Egil, Løkkegaard, Ellen

Publikováno v: Lidegaard, Nielsen L, Skovlund, Skjeldestad FE, Løkkegaard E. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ. British Medical Jo

Externí odkaz: https://hdl.handle.net/10037/25425

Maternal use of hormonal contraception and risk of childhood leukemia: A Scandinavian population-based cohort study.

Autor: Hemmingsen CH; Virus, Lifestyle and Genes, Danish Cancer Institute, Copenhagen, Denmark. Electronic address: cahe@cancer.dk., Kjaer SK; Virus, Lifestyle and Genes, Danish Cancer Institute, Copenhagen, Denmark; Department of Gynaecology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. Electronic address: susanne@cancer.dk., Hjorth S; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo, Oslo, Norway. Electronic address: s.h.andersen@farmasi.uio.no., Nörby U; Health and Medical Care Administration, Region Stockholm, Stockholm, Sweden. Electronic address: ulrika.norby@regionstockholm.se., Broe A; Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark; IQVIA, London, United Kingdom. Electronic address: anne.broe@iqvia.com., Pottegård A; Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark. Electronic address: apottegaard@health.sdu.dk., Bénévent J; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo, Oslo, Norway; Department of Medical and Clinical Pharmacology, Toulouse Faculty of Medicine, Centre Hospitalier Universitaire de Toulouse, Toulouse, France. Electronic address: justine.benevent@univ-tlse3.fr., Schmiegelow K; Department of Paediatrics and Adolescent Medicine, Juliane Marie Centre, Rigshospitalet, Copenhagen, Denmark; Institute of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark. Electronic address: kjeld.schmiegelow@regionh.dk., Skovlund CW; Cancer and Medicine, Danish Cancer Institute, Copenhagen, Denmark. Electronic address: charlotte.skovlund@gmail.com., Leinonen MK; Department of Data and Analytics, Finnish Institute for Health and Welfare, Helsinki, Finland; Teratology Information Service, Emergency Medicine and Services, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Electronic address: maarit.leinonen@thl.fi., Nordeng H; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo, Oslo, Norway; Department of Child Health and development, Norwegian Institute of Public Health, Oslo, Norway. Electronic address: h.m.e.nordeng@farmasi.uio.no., Mørch LS; Cancer and Medicine, Danish Cancer Institute, Copenhagen, Denmark. Electronic address: morch@cancer.dk., Hargreave M; Virus, Lifestyle and Genes, Danish Cancer Institute, Copenhagen, Denmark. Electronic address: mariehar@cancer.dk.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Dec 07; Vol. 215, pp. 115168. Date of Electronic Publication: 2024 Dec 07.

Depression risk in users of different doses of levonorgestrel intrauterine systems: a nationwide prospective cohort study.

Autor: Skovlund CW; Cancer and Medicine, The Danish Cancer Institute, Copenhagen, Denmark., Møller AL; Cancer and Medicine, The Danish Cancer Institute, Copenhagen, Denmark.; Department of Public Health, University of Copenhagen, Denmark., Torp-Pedersen C; Department of Public Health, University of Copenhagen, Denmark.; Department of Cardiology, North Zealand Hospital, Hillerød, Denmark., Mørch LS; Cancer and Medicine, The Danish Cancer Institute, Copenhagen, Denmark., Meaidi A; Cancer and Medicine, The Danish Cancer Institute, Copenhagen, Denmark.

Publikováno v: The Lancet regional health. Europe [Lancet Reg Health Eur] 2024 Jan 05; Vol. 38, pp. 100813. Date of Electronic Publication: 2024 Jan 05 (Print Publication: 2024).

Were cancer patients worse off than the general population during the COVID-19 pandemic? A population-based study from Norway, Denmark and Iceland during the pre-vaccination era.

Autor: Johansson ALV; Cancer Registry of Norway, P.O. Box 5313 Majorstuen, Oslo N-0304, Norway.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, P.O. Box 281, Stockholm SE-17177, Sweden., Skog A; Cancer Registry of Norway, P.O. Box 5313 Majorstuen, Oslo N-0304, Norway., Johannesen TB; Cancer Registry of Norway, P.O. Box 5313 Majorstuen, Oslo N-0304, Norway., Myklebust TÅ; Cancer Registry of Norway, P.O. Box 5313 Majorstuen, Oslo N-0304, Norway.; Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund, Norway., Skovlund CW; Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Danish Cancer Society, Strandboulevarden 49, Copenhagen DK-2100, Denmark., Mørch LS; Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Danish Cancer Society, Strandboulevarden 49, Copenhagen DK-2100, Denmark., Friis S; Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Danish Cancer Society, Strandboulevarden 49, Copenhagen DK-2100, Denmark., Gamborg M; Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Danish Cancer Society, Strandboulevarden 49, Copenhagen DK-2100, Denmark., Kristiansen MF; Center of Health Science, Faculty of Health Sciences, Tórshavn, Faroe Islands.; National Hospital of the Faroe Islands, Tórshavn, Faroe Islands., Pettersson D; National Board of Health and Welfare, Stockholm SE-106 30, Sweden., Ólafsdóttir EJ; ICS Research and Registration Center, Icelandic Cancer Society, P.O. Box 5420, 105 Reykjavík, Iceland., Birgisson H; ICS Research and Registration Center, Icelandic Cancer Society, P.O. Box 5420, 105 Reykjavík, Iceland., Palsson R; Landspitali-The National University Hospital of Iceland, Saemundargata 2, 102 Reykjavík, Iceland.; University of Iceland, Reykjavik, Iceland., Eythorsson E; Landspitali-The National University Hospital of Iceland, Saemundargata 2, 102 Reykjavík, Iceland., Irenaeus S; Regional Cancer Center Central Sweden, Akademiska Sjukhuset, Uppsala SE-751 85, Sweden.; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Lambe M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, P.O. Box 281, Stockholm SE-17177, Sweden.; Regional Cancer Center Central Sweden, Akademiska Sjukhuset, Uppsala SE-751 85, Sweden., Ursin G; Cancer Registry of Norway, P.O. Box 5313 Majorstuen, Oslo N-0304, Norway.; Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.; Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA.

Publikováno v: The Lancet regional health. Europe [Lancet Reg Health Eur] 2023 Jul 10; Vol. 31, pp. 100680. Date of Electronic Publication: 2023 Jul 10 (Print Publication: 2023).

The impact of the COVID-19 pandemic on cancer diagnosis based on pathology notifications: A comparison across the Nordic countries during 2020.

Autor: Johansson ALV; Cancer Registry of Norway, Oslo, Norway.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Larønningen S; Cancer Registry of Norway, Oslo, Norway., Skovlund CW; Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark., Kristiansen MF; Center of Health Science, Faculty of Health Sciences, Tórshavn, Faroe Islands.; National Hospital of the Faroe Islands, Tórshavn, Faroe Islands., Mørch LS; Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark., Friis S; Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark., Johannesen TB; Cancer Registry of Norway, Oslo, Norway., Myklebust TÅ; Cancer Registry of Norway, Oslo, Norway.; Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund, Norway., Skog A; Cancer Registry of Norway, Oslo, Norway., Pettersson D; National Board of Health and Welfare, Stockholm, Sweden., Birgisson H; Cancer Registry of Iceland, Icelandic Cancer Society, Reykjavik, Iceland., Virtanen A; Finnish Cancer Registry, Cancer Society of Finland, Helsinki, Finland., Malila N; Finnish Cancer Registry, Cancer Society of Finland, Helsinki, Finland., Pitkäniemi J; Finnish Cancer Registry, Cancer Society of Finland, Helsinki, Finland.; Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.; Department of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Tanskanen T; Finnish Cancer Registry, Cancer Society of Finland, Helsinki, Finland., Tryggvadóttir L; Cancer Registry of Iceland, Icelandic Cancer Society, Reykjavik, Iceland.; Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Ursin G; Cancer Registry of Norway, Oslo, Norway.; Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.; Department of Preventive Medicine, University of Southern California, Los Angeles, California, USA., Lambe M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Regional Cancer Center Central Sweden, Uppsala, Sweden.

Publikováno v: International journal of cancer [Int J Cancer] 2022 Aug 01; Vol. 151 (3), pp. 381-395. Date of Electronic Publication: 2022 Apr 25.